Konu "SARS-CoV-2" için Tıp Fakültesi Koleksiyonu listeleme
Toplam kayıt 16, listelenen: 1-16
-
Convalescent plasma therapy in patients with COVID-19
(Pergamon-Elsevier Science Ltd, 2021)Introduction: Passive antibody therapy has been used to immunize vulnerable people against infectious agents. In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and ... -
COVID-19 clinical course and blood groups: Turkish population-based study
(Tubitak Scientific & Technical Research Council Turkey, 2021)Background/aim: SARS-CoV-2 enters the cell through the binding of the S glycoprotein on the surface of the virus to the angiotensin-converting enzyme 2 (ACE-2) in the host cells and also SARS-CoV S protein binding to ACE-2 ... -
Decrease of left ventricular ejection fraction in severe illness patients due to COVID-19 may improve as the disease resolves
(Turkiye Klinikleri, 2021)Background/aim: Increase in publications supporting myocardial involvement in the COVID-19 disease has led to need to gain insight into the the global burden of heart failure after pandemic. We examined the course of ... -
The effects of allium sativum on immunity within the scope of COVID-19 infection
(Churchill Livingstone, 2020)The severity of coronavirus disease 2019 (COVID?19) infection is quite variable and the manifestations varies from asymptomatic disease to severe acute respiratory infection. Fever, dry cough, dyspnea, myalgia, fatigue, ... -
Evaluation of the chronic disease management and depression levels of people over 65 years of age during the COVID-19 pandemic period
(John Wiley and Sons Inc, 2021)Purpose: The present study aimed to determine the depression risk and the management of chronic diseases of individuals over 65 years old under the mandatory mass coronavirus disease 2019 quarantine. Design and Methods: ... -
Immunogenicity after CoronaVac vaccination
(Associacao Medica Brasileira, 2021)OBJECTIVE: This study aimed to investigate the seropositivity of CoronaVac-SinoVac vaccination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) risk factors and comorbidities. METHODS: Immunoglobulin (IgG) ... -
Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients
(Pergamon-Elsevier Science Ltd, 2021)SARS-CoV-2 attaches to the angiotensin-converting enzyme 2 (ACE-2) receptor on human cells. The virus causes hypercytokinemia, capillary leak, pulmonary edema, acute respiratory distress syndrome, acute cardiac injury, and ... -
Molecular approaches in COVID-19 treatment
(Nova Science Publishers, Inc., 2021)Coronaviruses are a family of enveloped RNA viruses that cause diseases in various mammals and birds. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus identified as the cause of a global ... -
A novel combined index of D-dimer, fibrinogen, albumin, and platelet (FDAPR) as mortality predictor of COVID-19
(Wolters Kluwer Medknow Publications, 2022)Background: In coronavirus disease 2019 (COVID-19) caused by SARSCoV2 viruses, coagulation abnormalities are strongly correlated between disease severity and mortality risk. Aims: The aim was to search for new indices to ... -
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
(Sage Publications Ltd, 2020)Introduction In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI). Method The data of 16 laboratory-confirmed COVID-19 patients with ... -
The outcome of COVID-19 in patients with hematological malignancy
(Wiley, 2021)In this study, we aim to report the outcomes for COVID-19 in patients with hematological malignancy in Turkey. Data from laboratory-confirmed 188 897 COVID-19 patients diagnosed between 11 March 2020 and 22 June 2020 ... -
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers
(Springer-Verlag Italia Srl, 2022)Previous studies reported that COVID-19 patients with cancer had higher rates of severe events such as intensive care unit (ICU) admission, mechanical ventilation (MV) assistance, and death during the COVID-19 course ... -
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic
(Turkiye Klinikleri, 2021)Background/aim: To evaluate treatment adherence and predictors of drug discontinuation among patients with inflammatory arthritis receiving bDMARDs within the first 100 days after the announcement of the COVID-19 pandemic. ... -
Relationship between serum soluble endothelial protein C receptor level and COVID-19 findings
(NLM (Medline), 2021)Coronavirus-related disease-2019 (COVID-19)-associated coagulopathy presents predominantly with thrombosis and leads to complications in close association with inflammatory process. Soluble endothelial protein C receptor ... -
The role of oxidized phospholipids in COVID-19-associated hypercoagulopathy
(Verduci Editore s.r.l, 2021)OBJECTIVE: There is more pronounced hypercoagulation in COVID-19 infection than in other viral lung infections. Oxidized phospholipids (OxPLs) appear in COVID-19-infected lungs due to oxidative stress, after which they ... -
Working conditions and anxiety levels of employees who have to work during the COVID-19 pandemic
(IOS Press BV, 2021)This study aims to evaluate the anxiety levels of employees by determining the working conditions and protective practices in the workplace of individuals who had to work during the COVID-19 pandemic. METHODS: The ...